FREE Account Opening + No Clearing Fees
Loading...

Ambey Laboratories IPO vs Visaman Global Sales IPO

Comparision between Ambey Laboratories IPO and Visaman Global Sales IPO.

IPO Details

Ambey Laboratories IPO is a SME Fixed Price Issue IPO proposed to list at NSE SME while Visaman Global Sales IPO is a SME Fixed Price Issue proposed to list at NSE SME.

  Ambey Laboratories IPO Visaman Global Sales IPO
Logo Ambey Laboratories IPO Logo Visaman Global Sales IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Book Built Issue Fixed Price Issue
Listing At NSE SME NSE SME
Lead Managers Fast Track Finsec Pvt Ltd Shreni Shares Limited
Registrar Link Intime India Private Ltd Link Intime India Private Ltd
Market Maker Nikunj Stock Brokers Limited Shreni Shares Limited
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Ambey Laboratories IPO is up to ₹44.68 Cr whereas the issue size of the Visaman Global Sales IPO is up to ₹16.05 Cr. The final issue price of Ambey Laboratories IPO is ₹68.00 per share and of Visaman Global Sales IPO is ₹43.00 per share.

  Ambey Laboratories IPO Visaman Global Sales IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower) ₹65.00 per share
Issue Price (Upper) ₹68.00 per share
Issue Price (Final) ₹68.00 per share ₹43.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 2000 shares 3000 shares
Fresh Issue Size 62,58,000 shares 37,32,000 shares
Fresh Issue Size (Amount) up to ₹42.55 Cr up to ₹16.05 Cr
OFS Issue Size 3,12,000 shares
OFS Issue Size (Amount) up to ₹2.12 Cr
Issue Size Total 65,70,000 shares 37,32,000 shares
Issue Size Total (Amount) up to ₹44.68 Cr up to ₹16.05 Cr

IPO Timetable

Ambey Laboratories IPO opens on Jul 04, 2024, while Visaman Global Sales IPO opens on Jun 24, 2024. The closing date of Ambey Laboratories IPO and Visaman Global Sales IPO is Jul 08, 2024, and Jun 26, 2024, respectively.

  Ambey Laboratories IPO Visaman Global Sales IPO
Anchor Bid Date Jul 03, 2024
Issue Open Jul 04, 2024 Jun 24, 2024
Issue Close Jul 08, 2024 Jun 26, 2024
Basis Of Allotment (Tentative) Jul 09, 2024 Jun 27, 2024
Initiation of Refunds (Tentative) Jul 10, 2024 Jun 28, 2024
Credit of Share (Tentative) Jul 10, 2024 Jun 28, 2024
Listing date (Tentative) Jul 11, 2024 Jul 01, 2024
Anchor Lockin End date 1 Aug 08, 2024
Anchor Lockin End date 2 Oct 07, 2024

Financials

Ambey Laboratories IPO P/E ratio is 27.81, as compared to Visaman Global Sales IPO P/E ratio of 38.25.

  Ambey Laboratories IPO Visaman Global Sales IPO
Financial

Ambey Laboratories Limited Financial Information (Restated)

Period Ended31 Jan 202431 Mar 202331 Mar 202231 Mar 2021
Assets8,620.845,761.855,592.944,461.80
Revenue10,043.6910,743.478,511.198,241.54
Profit After Tax607.73456.93357.471,033.67
Net Worth3,431.342,363.601,906.67-786.39
Reserves and Surplus1,562.46588.66131.73-1,275.74
Total Borrowing2,005.441,365.221,804.863,292.98
Amount in ₹ Lakhs

Visaman Global Sales Limited Financial Information (Restated)

Visaman Global Sales Limited's revenue increased by 16.04% and profit after tax (PAT) rose by 19.72% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended31 Dec 202331 Mar 202331 Mar 202231 Mar 2021
Assets8,001.695,863.953,982.422,727.20
Revenue20,691.3937,605.0132,407.2913,636.19
Profit After Tax101.61113.3394.6633.47
Net Worth1,095.31993.70660.38565.72
Reserves and Surplus395.31293.70180.3885.72
Total Borrowing5,690.854,345.691,386.10710.34
Amount in ₹ Lakhs
Promoter Shareholding (Pre-Issue) 94.97% 100.00%
Promoter Shareholding (Post-Issue) 69.90% 72.98%
P/E Ratio 27.81 38.25
Market Cap ₹171.64 Cr. ₹59.39 Cr.
ROE 20.80%% 9.28%%
ROCE 13.14%% 8.02%%
Debt/Equity 0.58 5.2
EPS ₹2.44 ₹1.12
RoNW 20.80%% 9.28%%

Shares Offered

In the Ambey Laboratories IPO retail investors (RII) are offered 21,84,000 shares while in Visaman Global Sales IPO retail investors are offered 21,84,000 shares. Qualified institutional buyers (QIB) are offered 12,52,000 shares in Ambey Laboratories IPO and 0 shares in Visaman Global Sales IPO.

  Ambey Laboratories IPO Visaman Global Sales IPO
Anchor Investor Reserveration 18,72,000 shares
Market Maker Reserveration 3,30,000 shares 1,92,000 shares
QIB 12,52,000 shares 0 shares
NII 6,06,001 shares 17,70,000 shares
RII 21,84,000 shares 17,70,000 shares
Employee 0 shares 0 shares
Others
Total 40,42,001 shares 35,40,000 shares

Bids Received (Subscription)

Ambey Laboratories IPO subscribed 173.18x in total, whereas Visaman Global Sales IPO subscribed 42.20x.

  Ambey Laboratories IPO Visaman Global Sales IPO
QIB (times) 61.90x
NII (times) 324.22x 28.12x
Big NII (times)
Small NII (times)
RII (times) 195.06x 51.54x
Employee (times)
Other (times)
Total (times) 173.18x 42.20x

Comments

Add a public comment...